The Zhitong Finance App learned that Johnson & Johnson (JNJ.US) released its third quarter earnings report on Tuesday. The report said that due to the sharp rise in sales of the cancer drug Darzalex, Q3 profit was higher than expected, while the full-year forecast was lowered to include a medical equipment acquisition transaction.

Zhitongcaijing · 10/15 12:01
The Zhitong Finance App learned that Johnson & Johnson (JNJ.US) released its third quarter earnings report on Tuesday. The report said that due to the sharp rise in sales of the cancer drug Darzalex, Q3 profit was higher than expected, while the full-year forecast was lowered to include a medical equipment acquisition transaction.